Tag archive for ‘Generic drug’
Niva Goldberg On Saturday, October 24th, 2015

Drugmaker offers $1 rival to $750 pill that sparked outrage

  A California, San Diego-based drugmaker Imprimis Pharmaceuticals, is offering a $1 rival to a prescription drug solely supplied by Turing Pharmaceuticals, whose 5, 000 percent price hike last More...

Jewish Business News On Thursday, October 1st, 2015

Teva acquires Mexican Rimsa pharmaceutical for $2.3 billion

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa,  an independent pharmaceutical company in Mexico with a portfolio of products and patents in Latin America and Europe More...

Niva Goldberg On Thursday, July 16th, 2015

Mylan battles against Teva takeover: US consumer groups oppose merger

“A takeover of Mylan by Teva is a bad deal for consumers, ” claim. US consumer organizations that have jointly written to the Federal Trade Commission (FTC) demanding that it block the Teva-Mylan More...

Teva launches generic migraine treatment

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has launched generic treatment is for migraine, Axert (almotriptan malate) tablets in 6.25 mg and 12.5 mg dosages, in the US. Teva is the first More...

Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: stop playing games with our company

Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...

Niva Goldberg On Thursday, May 28th, 2015

Teva Settles Cephalon Case With FTC for $1.2 Billion Over block generic drug competition

Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon Inc. blocked generic drug competition. Teva acquired More...

Ilan Shavit On Monday, March 30th, 2015

Teva Buying Auspex for $3.5 Billion in Anticipation of Competition over Copaxone

Read also: CEO Vigodman In Race To Save Teva Through ‘Inorganic Growth’ Just as JBN predicted (along with everybody else in the business) Teva Pharmaceutical Industries Ltd. Decided to buy a major generic More...

Joseph E. Stiglitz
Professor Joseph Stiglitz On Tuesday, February 10th, 2015

Nobel laureate in economics, Joseph Stiglitz: Obama Versus Obamacare

   The US Patient Protection and Affordable Care Act, President Barack Obama’s signature 2010 health-care reform, has succeeded in extending insurance coverage to millions of Americans who would not More...

Alan Gallindoss On Wednesday, June 12th, 2013

Israeli Teva and Indian Sun Pharmaceuticals to Pay $1.6 billion to Pfizer to Settle Drug Patent Infringement Case

– – / By Alan Gallindoss / Global pharmaceutical company Pfizer announced today that Israeli company Teva Pharmaceuticals Industries and Indian generic drug manufacturer Sun Pharmaceuticals have More...

Wordpress site Developed by Fixing WordPress Problems